Three Months Ended September 30,
|
||||||||||||||||
GAAP
|
Non-GAAP(1)
|
|||||||||||||||
2021
|
2020
|
2021
|
2020
|
|||||||||||||
(dollars in thousands, except per share data)
|
||||||||||||||||
Revenue
|
$
|
67,013
|
$
|
47,665
|
$
|
67,013
|
$
|
47,665
|
||||||||
Gross margin
|
44.3
|
%
|
42.7
|
%
|
44.5
|
%
|
42.8
|
%
|
||||||||
Income from operations
|
$
|
11,795
|
$
|
7,506
|
$
|
13,073
|
$
|
10,285
|
||||||||
Net income attributable to ACM Research, Inc.
|
$
|
10,155
|
$
|
8,627
|
$
|
12,352
|
$
|
8,969
|
||||||||
Basic EPS
|
$
|
0.52
|
$
|
0.47
|
$
|
0.64
|
$
|
0.49
|
||||||||
Diluted EPS
|
$
|
0.46
|
$
|
0.40
|
$
|
0.56
|
$
|
0.42
|
Nine Months Ended September 30,
|
||||||||||||||||
GAAP
|
Non-GAAP(1)
|
|||||||||||||||
2021
|
2020
|
2021
|
2020
|
|||||||||||||
(dollars in thousands, except per share data)
|
||||||||||||||||
Revenue
|
$
|
164,609
|
$
|
111,062
|
$
|
164,609
|
$
|
111,062
|
||||||||
Gross margin
|
42.2
|
%
|
45.0
|
%
|
42.3
|
%
|
45.1
|
%
|
||||||||
Income from operations
|
$
|
19,576
|
$
|
16,060
|
$
|
23,399
|
$
|
20,383
|
||||||||
Net income attributable to ACM Research, Inc.
|
$
|
22,192
|
$
|
10,251
|
$
|
24,198
|
$
|
17,568
|
||||||||
Basic EPS
|
$
|
1.16
|
$
|
0.57
|
$
|
1.27
|
$
|
0.97
|
||||||||
Diluted EPS
|
$
|
1.02
|
$
|
0.48
|
$
|
1.11
|
$
|
0.83
|
(1) |
Reconciliations to U.S. generally accepted accounting principles (GAAP) financial measures from non-GAAP financial measures are presented below under “Reconciliation of GAAP to Non-GAAP Financial Measures.” Non-GAAP financial measures
exclude stock-based compensation, and non-GAAP net income attributable to ACM Research, Inc. and basic and diluted EPS also exclude non-cash changes in fair value of financial assets and liabilities and unrealized gain (loss) on trading
securities.
|
•
|
Shipments. Total shipments in the third quarter of 2021 were $99 million, versus $59 million in the third quarter of 2020 and $82 million in the second quarter of 2021. Total shipments include deliveries for revenue in the
quarter and deliveries of first tool systems to customers for evaluation and potential revenue in future quarters.
|
•
|
SAPS Evaluation Tool Order. ACM received an evaluation tool order for its Ultra C SAPS frontside cleaning tool from a major global semiconductor manufacturer. The tool is expected to be installed for evaluation in the
prospective customer’s China-based development fab in the first quarter of 2022.
|
•
|
ECP Evaluation Tool Order. ACM Research received an evaluation tool order for its Ultra ECP map copper plating tool from a major Asia-based integrated circuit manufacturer. The tool is scheduled for delivery in early 2022 and
is subject to technical qualification and other commercial terms. The tool is configured with ACM’s Multi-Anode Partial Plating function, which allows the deposition of the copper metal layer on a dual-damascene structure for its
advanced technology nodes.
|
•
|
Tool Orders from Global IDM for WLP Wet Processing Tools. ACM received orders for two Ultra C pr wet stripping systems from a leading global integrated device manufacturer (IDM). The IDM plans to deploy these in its advanced packaging
manufacturing site in China for ease of use in photoresist (PR) removal in Wafer Level Packaging (WLP) applications. The first tool was delivered during in October of 2021, and the second tool is scheduled to be delivered in the first
quarter of 2022.
|
•
|
ECP Tool Orders for Wafer-Level Packaging from Compound
Semiconductor Customers. The Ultra ECP GIII plating tool supports WLP for compound semiconductors, with product offerings for silicon carbide (SiC), gallium nitride
(GaN) and gallium arsenide (GaAs). The tool is also capable of plating gold (Au) into backside deep hole processes with greater uniformity and better step coverage. The Company received two orders for the Ultra ECP GIII from China-based
compound semiconductor manufacturers. The first order was delivered in the second quarter of 2021 to support WLP with copper–nickel–tin-silver plating modules using second anode technology. The second order was delivered in the third
quarter of 2021 for a gold (Au) plating application.
|
•
|
ACM Shanghai IPO. The Shanghai Stock Exchange has announced the pricing of the ACM Shanghai’s STAR Market IPO. If completed, the STAR Market IPO is expected to result in gross proceeds to ACM Shanghai of RMB 3.685 billion
(approximately US$575 million as of November 4, 2021). The timing and successful completion of the STAR Market IPO and listing remain uncertain as they depend upon numerous factors beyond ACM Shanghai’s control.
|
•
|
Revenue was $67.0 million, up 40.6%, reflecting an increase in revenue from wet cleaning and other front-end processing tools, ECP ap tools, and advanced packaging, other advanced processing tools, services and spares.
|
•
|
Gross margin was 44.3%, up from 42.7%. Non-GAAP gross margin, which excludes stock-based compensation, was 44.5%, up from 42.8%. Gross margin was at the high end of the range of 40.0% to 45.0% set forth in the Company’s
long-term business model. The Company expects gross margin to vary from period to period due to a variety of factors, such as sales volume and product mix.
|
•
|
Operating expenses were $17.9 million, an increase of 39.4%. Non-GAAP operating expenses, which exclude stock-based compensation, were $16.7 million, up 65.5%. Non-GAAP operating expenses as a percent of revenue increased to
25.0% from 21.2%. Higher research and development spending on new products, expenses related to sales activities, and other expenses contributed to the increase from the prior-year period.
|
•
|
Operating income of $11.8 million reflected an increase of 57.1%. Non-GAAP operating income, which excludes stock-based compensation, was $13.1 million, up 27.1%.
|
•
|
Unrealized loss on trading securities was $0.9 million in the third quarter of 2021. The loss reflects the change in market value of ACM Shanghai’s indirect investment in STAR Market IPO shares of Semiconductor
Manufacturing International Corporation (SMIC), which began trading in mid-July 2020. The value was marked-to-market at quarter-end and is excluded from non-GAAP results.
|
•
|
Net income attributable to ACM Research, Inc. was $10.2 million, compared to $8.6 million. Non-GAAP net income attributable to ACM Research, Inc., which excludes stock-based compensation, unrealized gain on trading
securities, and change in fair value of financial liability, was $12.4 million as compared to $9.0 million. Tax-related items (compared to a normalized tax rate) and the effects of foreign-exchange fluctuations on operating results
provided a net benefit of $1.7 million, compared to $0.3 million.
|
•
|
Net income per diluted share attributable to ACM Research, Inc.
was $0.46, compared to $0.40. Non-GAAP net income per diluted share, which excludes stock-based compensation, unrealized gain on trading securities, and change in fair
value of financial liability, was $0.56, compared to $0.42. Tax-related items and the effects of foreign-exchange fluctuations on operating results resulted in a net benefit of $0.08 per share, compared to $0.02 per share.
|
•
|
Cash and equivalents at quarter-end were $65.0 million, versus $70.2 million at the end of the second quarter of 2021 and $71.8 million at the end of 2020. The quarter-over-quarter decrease was primarily due to cash flow used
by operating activities.
|
|
Phone Number
|
Toll-Free Number
|
United States |
+1 (661) 567-1217 |
+1 (833) 562-0137 |
Hong Kong | +852 5819 4851 |
+852 8009 66253 |
Mainland China |
+86 8008700169
|
|
|
+86 4006828609 |
In the United States:
|
The Blueshirt Group |
|
Ralph Fong |
|
+1 (415) 489-2195 |
|
ralph@blueshirtgroup.com
|
In China:
|
The Blueshirt Group Asia |
|
Gary Dvorchak, CFA |
|
+86 (138) 1079-1480 |
|
gary@blueshirtgroup.com |
Assets
|
September 30, 2021
|
December 31, 2020
|
||||||
(Unaudited)
(In thousands, except share and per share data)
|
||||||||
Current assets:
|
||||||||
Cash and cash equivalents
|
$
|
65,036
|
$
|
71,766
|
||||
Trading securities
|
30,219
|
28,239
|
||||||
Accounts receivable, less allowance for doubtful accounts of $0 as of September 30, 2021
and December 31, 2020
|
84,787
|
56,441
|
||||||
Other receivables
|
13,165
|
9,679
|
||||||
Inventories
|
176,609
|
88,639
|
||||||
Prepaid expenses
|
7,531
|
5,892
|
||||||
Total current assets
|
377,347
|
260,656
|
||||||
Property, plant and equipment, net
|
10,005
|
8,192
|
||||||
Land use right, net
|
9,556
|
9,646
|
||||||
Operating lease right-of-use assets, net
|
4,599
|
4,297
|
||||||
Intangible assets, net
|
556
|
554
|
||||||
Deferred tax assets
|
15,795
|
11,076
|
||||||
Long-term investments
|
7,408
|
6,340
|
||||||
Other long-term assets
|
44,243
|
40,496
|
||||||
Total assets
|
469,509
|
341,257
|
||||||
Liabilities and Stockholders’ Equity
|
||||||||
Current liabilities:
|
||||||||
Short-term borrowings
|
15,201
|
26,147
|
||||||
Current portion of long-term borrowings
|
2,351
|
1,591
|
||||||
Accounts payable
|
92,825
|
35,603
|
||||||
Advances from customers
|
52,681
|
17,888
|
||||||
Deferred revenue
|
2,403
|
1,343
|
||||||
Income taxes payable
|
1,233
|
31
|
||||||
FIN-48 payable
|
83
|
83
|
||||||
Other payables and accrued expenses
|
25,950
|
18,805
|
||||||
Current portion of operating lease liability
|
2,480
|
1,417
|
||||||
Total current liabilities
|
195,207
|
102,908
|
||||||
Long-term borrowings
|
23,080
|
17,979
|
||||||
Long-term operating lease liability
|
2,119
|
2,880
|
||||||
Deferred tax liability
|
1,293
|
1,286
|
||||||
Other long-term liabilities
|
5,303
|
8,034
|
||||||
Total liabilities
|
227,002
|
133,087
|
||||||
Commitments and contingencies
|
||||||||
Stockholders’ equity:
|
||||||||
Common stock – Class A, par value $0.0001: 150,000,000 shares authorized as of September
30, 2021 and 50,000,000 shares authorized as of December 31, 2020; 17,798,740 shares issued and outstanding as of September 30, 2021 and 16,896,693 shares issued and outstanding as of December 31, 2020
|
2
|
2
|
||||||
Common stock–Class B, par value $0.0001: 5,307,816 shares authorized as of September 30,
2021 and 2,409,738 shares authorized as of December 31, 2020; 1,707,605 shares issued and outstanding as of September 30, 2021 and 1,802,606 shares issued and outstanding as of December 31, 2020
|
-
|
-
|
||||||
Additional paid in capital
|
110,776
|
102,004
|
||||||
Accumulated surplus
|
56,479
|
34,287
|
||||||
Accumulated other comprehensive income
|
5,759
|
4,857
|
||||||
Total ACM Research, Inc. stockholders’ equity
|
173,016
|
141,150
|
||||||
Non-controlling interests
|
69,491
|
67,020
|
||||||
Total stockholders’ equity
|
242,507
|
208,170
|
||||||
Total liabilities and stockholders’ equity
|
$
|
469,509
|
$
|
341,257
|
Three Months Ended September 30,
|
Nine Months Ended September 30,
|
|||||||||||||||
2021
|
2020
|
2021
|
2020
|
|||||||||||||
(Unaudited)
|
(Unaudited)
|
|||||||||||||||
( In thousands, except share and per share data)
|
( In thousands, except share and per share data)
|
|||||||||||||||
Revenue
|
$
|
67,013
|
$
|
47,665
|
$
|
164,609
|
$
|
111,062
|
||||||||
Cost of revenue
|
37,328
|
27,324
|
95,199
|
61,137
|
||||||||||||
Gross profit
|
29,685
|
20,341
|
69,410
|
49,925
|
||||||||||||
Operating expenses:
|
||||||||||||||||
Sales and marketing
|
6,363
|
3,924
|
17,460
|
11,524
|
||||||||||||
Research and development
|
7,856
|
4,343
|
21,293
|
13,241
|
||||||||||||
General and administrative
|
3,671
|
4,568
|
11,081
|
9,100
|
||||||||||||
Total operating expenses, net
|
17,890
|
12,835
|
49,834
|
33,865
|
||||||||||||
Income from operations
|
11,795
|
7,506
|
19,576
|
16,060
|
||||||||||||
Interest income
|
33
|
179
|
113
|
834
|
||||||||||||
Interest expense
|
(191
|
)
|
(272
|
)
|
(574
|
)
|
(611
|
)
|
||||||||
Change in fair value of financial liability
|
-
|
(6,533
|
)
|
-
|
(11,964
|
)
|
||||||||||
Unrealized gain (loss) on trading securities
|
(919
|
)
|
8,970
|
1,817
|
8,970
|
|||||||||||
Other expenses, net
|
(255
|
)
|
(1,759
|
)
|
(683
|
)
|
(933
|
)
|
||||||||
Equity income in net income of affiliates
|
421
|
182
|
1,036
|
539
|
||||||||||||
Income before income taxes
|
10,884
|
8,273
|
21,285
|
12,895
|
||||||||||||
Income tax benefit (expense)
|
266
|
1,747
|
3,021
|
(416
|
)
|
|||||||||||
Net income
|
11,150
|
10,020
|
24,306
|
12,479
|
||||||||||||
Less: Net income attributable to non-controlling interests and redeemable non-controlling interests
|
995
|
1,393
|
2,114
|
2,228
|
||||||||||||
Net income attributable to ACM Research, Inc.
|
$
|
10,155
|
$
|
8,627
|
$
|
22,192
|
$
|
10,251
|
||||||||
Comprehensive income:
|
||||||||||||||||
Net income
|
11,150
|
10,020
|
24,306
|
12,479
|
||||||||||||
Foreign currency translation adjustment
|
(409
|
)
|
5,757
|
1,259
|
4,099
|
|||||||||||
Comprehensive Income
|
10,741
|
15,777
|
25,565
|
16,578
|
||||||||||||
Less: Comprehensive income attributable to non-controlling interests and redeemable non-controlling interests
|
757
|
2,698
|
2,471
|
3,614
|
||||||||||||
Comprehensive income attributable to ACM Research, Inc.
|
$
|
9,984
|
$
|
13,079
|
$
|
23,094
|
$
|
12,964
|
||||||||
|
||||||||||||||||
Net income attributable to ACM Research, Inc. per common share:
|
||||||||||||||||
Basic
|
$
|
0.52
|
$
|
0.47
|
$
|
1.16
|
$
|
0.57
|
||||||||
Diluted
|
$
|
0.46
|
$
|
0.40
|
$
|
1.02
|
$
|
0.48
|
||||||||
|
||||||||||||||||
Weighted average common shares outstanding used in computing per share amounts:
|
||||||||||||||||
Basic
|
19,422,546
|
18,201,943
|
19,113,353
|
18,124,665
|
||||||||||||
Diluted
|
22,042,516
|
21,555,296
|
21,730,340
|
21,257,661
|
Three Months Ended September 30,
|
Nine Months Ended September 30,
|
|||||||||||||||
Total Revenue By Product Category
|
2021
|
2020
|
2021
|
2020
|
||||||||||||
Single Wafer Cleaning Tools (SAPS, TEBO, Tahoe) and Semi-Critical Cleaning Equipment
|
$
|
49,448
|
$
|
38,344
|
$
|
127,322
|
$
|
94,468
|
||||||||
ECP (front-end and packaging), Furnace and Other Technologies
|
8,200
|
4,850
|
13,750
|
9,340
|
||||||||||||
Advanced Packaging (excluding ECP), and Services & Spare Parts
|
9,365
|
4,471
|
23,537
|
7,254
|
||||||||||||
$
|
67,013
|
$
|
47,665
|
$
|
164,609
|
$
|
111,062
|
Three Months Ended September 30,
|
Nine Months Ended September 30,
|
|||||||||||||||
Total Revenue By Equipment Type (Front-end / Back-end)
|
2021
|
2020
|
2021
|
2020
|
||||||||||||
Wet cleaning and other front-end processing tools
|
$
|
49,448
|
$
|
38,344
|
$
|
127,322
|
$
|
98,958
|
||||||||
Advanced packaging, other processing tools, services & spares
|
17,565
|
9,321
|
37,287
|
12,104
|
||||||||||||
$
|
67,013
|
$
|
47,665
|
$
|
164,609
|
$
|
111,062
|
|||||||||
Three Months Ended September 30,
|
Nine Months Ended September 30,
|
|||||||||||||||
Total Revenue By Region
|
2021
|
2020
|
2021
|
2020
|
||||||||||||
Mainland China
|
$
|
66,887
|
$
|
46,881
|
$
|
164,319
|
$
|
110,174
|
||||||||
Other Regions
|
126
|
784
|
290
|
888
|
||||||||||||
$
|
67,013
|
$
|
47,665
|
$
|
164,609
|
$
|
111,062
|
Three Months Ended September 30,
|
||||||||||||||||||||||||||||||||
2021
|
2020
|
|||||||||||||||||||||||||||||||
Actual
|
SBC
|
Other non-operating adjustments
|
Adjusted
|
Actual
|
SBC
|
Other non-operating adjustments
|
Adjusted
|
|||||||||||||||||||||||||
(GAAP)
|
(Non-GAAP)
|
(GAAP)
|
(Non-GAAP)
|
|||||||||||||||||||||||||||||
($ in thousands)
|
||||||||||||||||||||||||||||||||
Revenue
|
$
|
67,013
|
$
|
-
|
$
|
-
|
$
|
67,013
|
$
|
47,665
|
$
|
-
|
$
|
-
|
$
|
47,665
|
||||||||||||||||
Cost of revenue
|
(37,328
|
)
|
(108
|
)
|
-
|
(37,220
|
)
|
(27,324
|
)
|
(44
|
)
|
-
|
(27,280
|
)
|
||||||||||||||||||
Gross profit
|
29,685
|
(108
|
)
|
-
|
29,793
|
20,341
|
(44
|
)
|
-
|
20,385
|
||||||||||||||||||||||
Gross margin %
|
44.3
|
%
|
0.2
|
%
|
44.5
|
%
|
42.7
|
%
|
0.1
|
%
|
42.8
|
%
|
||||||||||||||||||||
Operating expenses:
|
||||||||||||||||||||||||||||||||
Sales and marketing
|
(6,363
|
)
|
(417
|
)
|
-
|
(5,946
|
)
|
(3,924
|
)
|
(237
|
)
|
-
|
(3,687
|
)
|
||||||||||||||||||
Research and development
|
(7,856
|
)
|
(293
|
)
|
-
|
(7,563
|
)
|
(4,343
|
)
|
(193
|
)
|
-
|
(4,150
|
)
|
||||||||||||||||||
General and administrative
|
(3,671
|
)
|
(460
|
)
|
-
|
(3,211
|
)
|
(4,568
|
)
|
(2,305
|
)
|
-
|
(2,263
|
)
|
||||||||||||||||||
Income from operations
|
$
|
11,795
|
$
|
(1,278
|
)
|
$
|
-
|
$
|
13,073
|
$
|
7,506
|
$
|
(2,779
|
)
|
$
|
-
|
$
|
10,285
|
||||||||||||||
Operating margin %
|
17.6
|
%
|
1.9
|
%
|
-
|
19.5
|
%
|
15.7
|
%
|
5.8
|
%
|
-
|
21.6
|
%
|
||||||||||||||||||
Change in fair value of financial liability
|
-
|
-
|
-
|
-
|
(6,533
|
)
|
-
|
(6,533
|
)
|
-
|
||||||||||||||||||||||
Unrealized gain (loss) on trading securities
|
(919
|
)
|
-
|
(919
|
)
|
-
|
8,970
|
-
|
8,970
|
-
|
||||||||||||||||||||||
Net income (loss) attributable to ACM Research, Inc.
|
$
|
10,155
|
$
|
(1,278
|
)
|
$
|
(919
|
)
|
$
|
12,352
|
$
|
8,627
|
$
|
(2,779
|
)
|
$
|
2,437
|
$
|
8,969
|
|||||||||||||
Basic EPS
|
$
|
0.52
|
$
|
0.64
|
$
|
0.47
|
$
|
0.49
|
||||||||||||||||||||||||
Diluted EPS
|
$
|
0.46
|
$
|
0.56
|
$
|
0.40
|
$
|
0.42
|
Nine Months Ended September 30,
|
||||||||||||||||||||||||||||||||
2021
|
2020
|
|||||||||||||||||||||||||||||||
Actual
|
SBC
|
Other non-operating adjustments
|
Adjusted
|
Actual
|
SBC
|
Other non-operating adjustments
|
Adjusted
|
|||||||||||||||||||||||||
(GAAP)
|
(Non-GAAP)
|
(GAAP)
|
(Non-GAAP)
|
|||||||||||||||||||||||||||||
($ in thousands)
|
||||||||||||||||||||||||||||||||
Revenue
|
$
|
164,609
|
$
|
-
|
$
|
-
|
$
|
164,609
|
$
|
111,062
|
$
|
-
|
$
|
-
|
$
|
111,062
|
||||||||||||||||
Cost of revenue
|
(95,199
|
)
|
(289
|
)
|
-
|
(94,910
|
)
|
(61,137
|
)
|
(132
|
)
|
-
|
(61,005
|
)
|
||||||||||||||||||
Gross profit
|
69,410
|
(289
|
)
|
-
|
69,699
|
49,925
|
(132
|
)
|
-
|
50,057
|
||||||||||||||||||||||
Gross margin %
|
42.2
|
%
|
0.2
|
%
|
42.3
|
%
|
45.0
|
%
|
0.1
|
%
|
45.1
|
%
|
||||||||||||||||||||
Operating expenses:
|
||||||||||||||||||||||||||||||||
Sales and marketing
|
(17,460
|
)
|
(1,400
|
)
|
-
|
(16,060
|
)
|
(11,524
|
)
|
(495
|
)
|
-
|
(11,029
|
)
|
||||||||||||||||||
Research and development
|
(21,293
|
)
|
(801
|
)
|
-
|
(20,492
|
)
|
(13,241
|
)
|
(568
|
)
|
-
|
(12,673
|
)
|
||||||||||||||||||
General and administrative
|
(11,081
|
)
|
(1,333
|
)
|
-
|
(9,748
|
)
|
(9,100
|
)
|
(3,128
|
)
|
-
|
(5,972
|
)
|
||||||||||||||||||
Income from operations
|
$
|
19,576
|
$
|
(3,823
|
)
|
$
|
-
|
$
|
23,399
|
$
|
16,060
|
$
|
(4,323
|
)
|
$
|
-
|
$
|
20,383
|
||||||||||||||
Operating margin %
|
11.9
|
%
|
2.3
|
%
|
-
|
14.2
|
%
|
14.5
|
%
|
3.9
|
%
|
-
|
18.4
|
%
|
||||||||||||||||||
Change in fair value of financial liability
|
-
|
-
|
-
|
-
|
(11,964
|
)
|
-
|
(11,964
|
)
|
-
|
||||||||||||||||||||||
Unrealized gain on trading securities
|
1,817
|
-
|
1,817
|
-
|
8,970
|
-
|
8,970
|
-
|
||||||||||||||||||||||||
Net income attributable to ACM Research, Inc.
|
$
|
22,192
|
$
|
(3,823
|
)
|
$
|
1,817
|
$
|
24,198
|
$
|
10,251
|
$
|
(4,323
|
)
|
$
|
(2,994
|
)
|
$
|
17,568
|
|||||||||||||
Basic EPS
|
$
|
1.16
|
$
|
1.27
|
$
|
0.57
|
$
|
0.97
|
||||||||||||||||||||||||
Diluted EPS
|
$
|
1.02
|
$
|
1.11
|
$
|
0.48
|
$
|
0.83
|